Transgender Clinical Trials 2024

Transgender Clinical Trials 2024

Transgender research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in transgender clinical trials today.

Transgender Clinical Trials

Here are the 6 most popular medical studies for transgender

Popular filter options for transgender trials

HIV Clinical Trials

View 9 HIV medical studies.

Transgender Clinical Trials With No Placebo

View 32 transgender medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to transgender

What are the top hospitals conducting transgender research?

In recent years, there has been a growing recognition of the unique healthcare needs of transgender individuals. Hospital institutions across the United States have taken strides to address these needs through clinical trials focusing on transgender health. One such institution is the University of Wisconsin in Madison, which currently has three ongoing trials specifically dedicated to transgender patients. Although relatively new to this field, with only two recorded trials thus far and their first trial documented in 2024, their commitment to advancing transgender healthcare is commendable.

Moving over to the West Coast, San Francisco’s Bridge HIV CRS plays a pioneering role in addressing the medical concerns faced by transgender individuals. With two active clinical trials underway and no previous recorded studies exclusively focused on transgender health, this hospital demonstrates a forward-thinking approach that aims to bridge gaps in knowledge regarding effective interventions for this community.

Similarly, New york's Harlem Prevention Center CRS and Philadelphia's Penn Prevention CRS are also actively engaged in two ongoing transgender clinical trials each but do not have any prior history of conducting specific research for gender-affirming healthcare before now.

Meanwhile, Houston AIDS Research Team CRS stands as another key player striving towards improving trans-inclusive care by running two current clinical studies centered around transgender participants but like some others mentioned hasn't conducted any past investigations related solely toward this population till date.

These hospitals signify significant progress within the medical community when it comes to acknowledging and accommodating diverse identities within healthcare research. By devoting resources and expertise toward understanding and addressing the unique challenges faced by transgender individuals, these institutions are driving advancements that will ultimately lead to a more inclusive and supportive future for all members of society.

Which are the best cities for transgender clinical trials?

When it comes to transgender clinical trials, several cities stand out as hubs for research and development. New york, with its 16 active trials, offers studies like Group 1: BIC-treated and Arm A. Chicago follows closely behind with 7 ongoing trials focusing on interventions such as Focus Groups and F/TAF. Los Angeles also plays a significant role, hosting 6 active trials examining treatments like Prep N' Shine: Strength Based Case Management (Stage 1) and Surgery-specific general anesthetic + ultrasound guided peripheral nerve block #2. Lastly, San Francisco and Houston each have 5 active trials contributing to the advancement of transgender healthcare. These cities provide valuable opportunities for individuals in the transgender community to participate in cutting-edge clinical research that can lead to improved care options tailored specifically to their needs.

Which are the top treatments for transgender being explored in clinical trials?

In the realm of transgender healthcare, clinical trials are paving the way for innovative treatments. The top contenders currently being explored in these trials include:

  • Hormone Replacement Therapy (HRT): Studying different hormone regimens and delivery methods to optimize physical transition
  • Gender-Affirming Surgeries: Investigating techniques and outcomes of various surgical procedures like chest reconstruction or genital reconstruction
  • Voice Therapy: Exploring interventions to help individuals modify their vocal pitch and resonance to align with their gender identity These ongoing studies aim to enhance the quality of care available for transgender individuals, providing them with more options and personalized treatment approaches.
What are the most recent clinical trials for transgender?

Exciting progress is being made in the field of transgender healthcare through recent clinical trials. One such trial investigates the effectiveness of Clascoterone, a potential treatment for individuals undergoing gender transition. This trial spans both Phase 1 and Phase 2, offering hope for enhanced hormone therapy options. Additionally, an ongoing Phase 4 study called Enhanced Implementation (EI) focuses on improving the implementation of transgender healthcare practices to ensure optimal outcomes and accessibility. Another significant trial explores surgery-specific general anesthesia combined with ultrasound-guided peripheral nerve block #2 as a means to improve surgical experiences for transgender patients. Furthermore, a Phase 2 study examines the efficacy of twice-daily sublingual estradiol plus spironolactone in hormone therapy regimens tailored specifically towards transgender individuals. These groundbreaking trials mark important steps forward in enhancing care and well-being within the transgender community.

What transgender clinical trials were recently completed?

Recently completed clinical trials have focused on advancing transgender healthcare and addressing the unique needs of this community. Notable among them is a trial conducted by University College London that investigated hormone therapy for transgender individuals, with results expected to shape future treatment approaches. Another significant study, led by The Fenway Institute in Boston, examined the impact of gender-affirming surgeries on mental health outcomes in transgender people. These groundbreaking trials contribute valuable insights into improving the overall well-being and quality of care for transgender individuals.